Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AMIGO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TM2D3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM120B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASSF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRELD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MADD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF160 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SKAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST3H2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6805 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGCC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSR4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX4I1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERTAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFE2L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDCL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on